Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Trop Pediatr ; 64(6): 531-538, 2018 Dec 01.
Article in English | MEDLINE | ID: mdl-29365196

ABSTRACT

OBJECTIVE: The objective of this article was to study the effect of antenatal dexamethasone on the respiratory morbidity of late preterm newborns. STUDY DESIGN: A randomized controlled trial, conducted in Obstetrics and Gynecology Department in collaboration with Neonatology department at JIPMER, India. In total, 155 women were studied in each group. Intention to treat analysis and per protocol analysis were done. RESULTS: Overall 31 (10%) newborns were admitted to intensive care unit. The composite respiratory morbidity (defined as respiratory distress syndrome and/or transient tachypnea of newborn) was observed in 64 (41.6%) infants in the study and 56 (36.2%) infants in the control group. On multivariable-adjusted analysis, use of steroids was not found to be associated with decrease in composite respiratory morbidity [adjusted relative risk 0.91 (95% confidence interval: 0.7-1.2)]. CONCLUSIONS: Antenatal dexamethasone does not reduce the composite respiratory morbidity of babies born vaginally or by emergency cesarean to women with late preterm labor.


Subject(s)
Dexamethasone/therapeutic use , Glucocorticoids/therapeutic use , Prenatal Care , Respiratory Distress Syndrome, Newborn/epidemiology , Transient Tachypnea of the Newborn/epidemiology , Cesarean Section , Female , Glucocorticoids/administration & dosage , Humans , India/epidemiology , Infant, Newborn , Infant, Premature , Intensive Care Units, Neonatal , Morbidity , Pregnancy , Premature Birth , Prenatal Care/methods , Prenatal Exposure Delayed Effects , Respiratory Distress Syndrome, Newborn/prevention & control , Transient Tachypnea of the Newborn/prevention & control , Treatment Outcome
2.
J Matern Fetal Neonatal Med ; 31(12): 1548-1553, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28412854

ABSTRACT

BACKGROUND: Preeclamptic mothers are likely to have increased oxidative stress during pregnancy which can adversely affect the outcome in their neonates. OBJECTIVES: To measure the oxidative stress in preeclamptic mother- newborn dyads and correlate it with the immediate neonatal outcome. METHODS: This case control study conducted in a tertiary care teaching hospital, South India included 71 preeclamptic mothers - newborn dyads (cases) and 72 normal mothers - newborn dyads (controls). Biochemical parameters including total antioxidant status (TAS), protein carbonyls and malondialdehyde levels (MDA) were measured in both maternal and cord blood. Association between these oxidative stress parameters and early neonatal outcome was studied. RESULTS: All oxidative stress markers were higher in the preeclampsia group compared to the controls. Cord blood protein carbonyl levels had significant correlation with maternal levels. Prematurity, low-birth weight, respiratory distress syndrome (RDS), early onset sepsis (EOS) and intra-uterine growth restriction (IUGR) were more among cases. Early neonatal outcomes like death, IUGR, EOS, and RDS had significant correlation with protein carbonyl levels among the cases. CONCLUSIONS: Oxidative stress is increased in preeclamptic mother - newborn dyads. Increased protein carbonyl levels in preeclampsia correlate with adverse early neonatal outcome.


Subject(s)
Infant, Newborn, Diseases/metabolism , Oxidative Stress , Pre-Eclampsia/metabolism , Adult , Case-Control Studies , Female , Humans , Infant, Newborn , Pregnancy , Young Adult
3.
Cureus ; 10(10): e3492, 2018 Oct 24.
Article in English | MEDLINE | ID: mdl-30648034

ABSTRACT

Aim Our study aimed to evaluate the early neurodevelopmental outcomes of very low birthweight (VLBW) neonates with culture-proven sepsis compared with VLBW neonates without sepsis. Materials and methods Our study included 80 VLBW neonates with blood culture-proven sepsis and 80 VLBW neonates without sepsis. For each neonate with sepsis, a control neonate of matching gender and gestational age was selected. We evaluated weight, length, and head circumference and conducted Hammersmith neonatal neurological examinations for each participant. We also conducted Developmental Assessment Screening II and vision and hearing impairment screening during a follow-up evaluation. Results We noted a developmental delay in 11 (23.4%) neonates with sepsis and two (3%) without sepsis at six months of age. The median developmental quotient, motor quotient, and mental quotients were significantly lower in the neonates with sepsis compared to those without sepsis. Conclusions Our findings suggest that sepsis significantly affects mortality and neurodevelopmental outcomes at six months in VLBW neonates. Therefore, preventive measures for sepsis in VLBW neonates is crucial, and those with culture-positive sepsis will require close monitoring and follow-up evaluations.

5.
J Trop Pediatr ; 59(1): 17-22, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22907998

ABSTRACT

OBJECTIVES: To evaluate in term babies with perinatal asphyxia, the effect of therapeutic hypothermia (TH) on oxidative stress and neurological outcome at discharge. METHODS: Babies who satisfied inclusion criteria were randomized to TH, with cooling gel packs to a target temperature of 33-34°C for 72 h or normothermia. Blood sample was collected before and after TH for oxidative stress assessment: total antioxidant status (TAS) and malondialdehyde (MDA). RESULTS: Of 116 babies randomized, there was no statistically significant difference in the baseline TAS and MDA. After 72 h of TH, TAS was significantly higher (p = <0.001) (761.69 ± 114.01 vs. 684.16 ± 88.86) and MDA was significantly lower (p = <0.001) in TH group (1.73 ± 0.66 vs. 5.2 ± 1.06). Risk of developing deficit was lower (p < 0.001) in TH group with relative risk of 0.49 and 95 % confidence interval: 0.29-0.68. CONCLUSION: TH reduces oxidative stress and improves neurological outcome in perinatal asphyxia. TRIAL REGISTRATION NUMBER: CTRI/2011/12/002196.


Subject(s)
Asphyxia Neonatorum/therapy , Hypothermia, Induced/methods , Oxidative Stress/physiology , Adult , Antioxidants/analysis , Gestational Age , Humans , Hypoxia-Ischemia, Brain/therapy , Infant , Infant, Newborn , Malondialdehyde , Single-Blind Method , Treatment Outcome
6.
Neonatology ; 99(4): 355-66, 2011.
Article in English | MEDLINE | ID: mdl-21701209

ABSTRACT

BACKGROUND: Since the first successful report of surfactant replacement therapy (SRT) in infants with respiratory distress syndrome (RDS), numerous randomized clinical trials have shown that SRT reduces mortality and morbidity in RDS. Surfactant is now a standard therapy for RDS. However, the use of SRT in the developing world has been extremely slow. OBJECTIVE: The objective of this paper is to review the published information regarding the usage and barriers encountered in the use of SRT in developing countries. METHODS: We reviewed the available literature and also gathered information from countries with a high burden of prematurity and high infant mortality rate regarding replacement therapy and the barriers to use of SRT. RESULTS: We reviewed the available literature and found that developing countries bear a high burden of prematurity and RDS that contribute to high neonatal and infant mortality rates. Based on the effectiveness of SRT in RDS, surfactant preparations were included in the Essential Drug List of WHO in 2008. However, the use of SRT in developing countries is still limited because of (1) high cost, (2) lack of skilled personnel to administer SRT, and (3) lack of support systems after the SRT. The cost of SRT may exceed the per-capita GNP (300-500 USD) in some countries. Data from India and South Africa suggests that SRT is limited to rescue therapy in babies with potential for better survival, usually >28 weeks' gestation. Recent studies show that infants with RDS respond well to initial continuous positive airway pressure (CPAP) followed by SRT for those who do not respond. CONCLUSIONS: In developing countries, CPAP may be used as the primary mode of management of RDS. SRT may be reserved for non-responders to CPAP. Alternate simpler methods of delivery of surfactant (aerosol technique) are also being explored. There is a need for further studies to develop and assess efficient and less expensive methods of application of CPAP and SRT in developing countries.


Subject(s)
Developing Countries , Pulmonary Surfactants/therapeutic use , Respiratory Distress Syndrome, Newborn/drug therapy , Communication Barriers , Developing Countries/statistics & numerical data , Female , Humans , Infant Mortality , Infant, Newborn , Infant, Premature/physiology , Pregnancy , Respiratory Distress Syndrome, Newborn/mortality
7.
Indian J Pediatr ; 77(10): 1093-5, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20886318

ABSTRACT

OBJECTIVE: To study the clinical profile and outcome of children screened and diagnosed for Swine flu at a tertiary care hospital. METHODS: All Children with suspicion of swine flu infection attending our hospital during the epidemic from August 2009 through January 2010 were screened and categorized into A, B and C as per guidelines of National Health and family welfare. Patients in Category A were advised home quarantine, Category B tested and treated with ostelamivir and Category C were hospitalized. RESULTS: Among 424 cases screened for Swine flu, 79 were children in the age group 0-12 years of age (18.6%). The median age of presentation was 5 years. Children belonging to Category A were 43(54.4%), Category B were 31(39.2%) and Category C were 5(6.3%). Out of the cases that were screened, 19 children were confirmed positive for H1N1 infection(30.2%).Out of positive cases 8 were in category A (42%), eight were in category B (42%) and five were in category C (26.3%). CONCLUSIONS: During the epidemic of swine flu at puducherry, majority of cases were category A with mild symptoms. Home quarantine and preventive measures during the epidemic were found to be far more important than testing and treating with Oseltamivir.


Subject(s)
Influenza A Virus, H1N1 Subtype , Influenza, Human/diagnosis , Antiviral Agents/therapeutic use , Child , Child, Preschool , Female , Humans , India , Infant , Infant, Newborn , Influenza, Human/drug therapy , Male , Oseltamivir/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...